NCT02197494View on ClinicalTrials.gov

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy
Interventions
DRUG

Valsartan

320mg tablets

Trial Locations (1)

400 614

Lambda Therapeutic Research Ltd., Navi Mumbai

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT02197494 - Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter